Skip to main content

Rockefeller Capital Management L.P.

Position in NBIX — Neurocrine Biosciences Inc

CIK 1739439 NEW YORK, NY

Position in NBIX

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$62,957,776
+$25,794,319 QoQ
Shares Held
373,548
+32.4% QoQ
Ownership
0.367%
of shares outstanding
% of Portfolio
0.14%
of 13F equity value
Holder Rank
#47
of 772 holders
Holding Since
Mar 2020
23 quarters on record
Voting authority Sole 76% Shared 0% None 24%

Common Shares in NBIX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

Rockefeller Capital Management L.P. holds $105,853,317 across 51 Drug Manufacturers - Specialty & Generic names. NBIX ranks #1 (59.5% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 NBIX
Neurocrine Biosciences Inc
This page
373,548 $62,957,776

All Filings in NBIX

Export CSV
23 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $62,957,776 373,548
2026-03-31 $37,163,457 282,097
2025-12-31 $39,899,613 281,320
2025-09-30 $27,226,418 193,948
2025-06-30 $14,231,751 113,229
2025-03-31 $2,388,849 21,599
2024-12-31 $2,712,254 19,870
2024-09-30 $2,226,165 19,321
2024-06-30 $2,653,864 19,277
2023-06-30 $654,913 6,945
2023-03-31 $680,804 6,726
2022-12-31 $838,587 7,021
2022-09-30 $751,966 7,080
2022-06-30 $704,682 7,229
2022-03-31 $1,175,811 12,542
2021-12-31 $1,085,149 12,741
2021-09-30 $2,054,486 21,421
2021-06-30 $60,408,566 620,721
2021-03-31 $60,576,732 622,897
2020-12-31 $58,170,597 606,892
2020-09-30 $32,036,664 333,160
2020-06-30 $40,613,922 332,901
2020-03-31 $27,029,044 312,294